Related Experiment Video
Updated: Mar 8, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem cell therapy for ischemic heart diseases
Hong Yu1,2, Kai Lu1,2,3, Jinyun Zhu1,2
1Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, P.R. China.
Insights
Stem cell therapy shows promise for treating heart damage after myocardial infarction. Research is exploring stem cell-derived exosomes for more effective, cell-free treatments for ischemic heart diseases.
Area of Science:
- Cardiology
- Regenerative Medicine
- Biotechnology
Background:
- Ischemic heart diseases, particularly myocardial infarction, are a leading cause of heart failure (HF).
- Current HF treatments delay progression but do not repair damaged heart tissue.
- Heart transplantation is limited by donor availability, necessitating alternative therapies.
Purpose of the Study:
- To review the potential of stem cell-based therapies for repairing myocardial damage.
- To identify areas of agreement and controversy in current stem cell therapy research for ischemic heart disease.
- To highlight emerging research directions, including stem cell-derived exosomes and cell reprogramming.
Main Methods:
- Literature review of recent publications.
- Analysis of data from ClinicalTrials.gov.
- Synthesis of findings on stem cell types, delivery methods, and mechanisms of action.
Main Results:
- Stem cell-based therapy is a promising strategy for damaged myocardium, with various stem cell types showing potential.
- Significant variability exists in the efficacy of cell therapies, influenced by cell type, source, delivery, and dosage.
- Stem cell-derived exosomes are emerging as key players in paracrine mechanisms and offer potential for cell-free therapy.
Conclusions:
- Stem cell-based therapy holds significant promise for treating ischemic heart diseases and heart failure.
- Further research into optimizing cell types, delivery, and understanding mechanisms is crucial.
- Exosomes derived from stem cells represent a promising avenue for future cell-free therapeutic strategies in cardiovascular disease.
Introduction:
Ischemic heart diseases, especially the myocardial infarction, is a major hazard problem to human health. Despite substantial advances in control of risk factors and therapies with drugs and interventions including bypass surgery and stent placement, the ischemic heart diseases usually result in heart failure (HF), which could aggravate social burden and increase the mortality rate. The current therapeutic methods to treat HF stay at delaying the disease progression without repair and regeneration of the damaged myocardium. While heart transplantation is the only effective therapy for end-stage patients, limited supply of donor heart makes it impossible to meet the substantial demand from patients with HF. Stem cell-based transplantation is one of the most promising treatment for the damaged myocardial tissue.
Sources Of Data:
Key recent published literatures and ClinicalTrials.gov.
Areas Of Agreement:
Stem cell-based therapy is a promising strategy for the damaged myocardial tissue. Different kinds of stem cells have their advantages for treatment of Ischemic heart diseases.
Areas Of Controversy:
The efficacy and potency of cell therapies vary significantly from trial to trial; some clinical trials did not show benefit. Diverged effects of cell therapy could be affected by cell types, sources, delivery methods, dose and their mechanisms by which delivered cells exert their effects.
Growing Points:
Understanding the origin of the regenerated cardiomyocytes, exploring the therapeutic effects of stem cell-derived exosomes and using the cell reprogram technology to improve the efficacy of cell therapy for cardiovascular diseases.
Areas Timely For Developing Research:
Recently, stem cell-derived exosomes emerge as a critical player in paracrine mechanism of stem cell-based therapy. It is promising to exploit exosomes-based cell-free therapy for ischemic heart diseases in the future.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:17Stem Cell Culture
01:22iPS Cell Differentiation
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...